Page last updated: 2024-10-22

amiodarone and Infusion Site Adverse Event

amiodarone has been researched along with Infusion Site Adverse Event in 1 studies

Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.

Research Excerpts

ExcerptRelevanceReference
"A 63-year-old man underwent cardioversion of atrial fibrillation with intravenous amiodarone through an antecubital fossa cannula."7.91Focal myositis and contracture secondary to amiodarone extravasation from a peripheral cannula. ( Cordato, D; Ledingham, D, 2019)
"A 63-year-old man underwent cardioversion of atrial fibrillation with intravenous amiodarone through an antecubital fossa cannula."3.91Focal myositis and contracture secondary to amiodarone extravasation from a peripheral cannula. ( Cordato, D; Ledingham, D, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ledingham, D1
Cordato, D1

Other Studies

1 other study available for amiodarone and Infusion Site Adverse Event

ArticleYear
Focal myositis and contracture secondary to amiodarone extravasation from a peripheral cannula.
    BMJ case reports, 2019, Jan-18, Volume: 12, Issue:1

    Topics: Amiodarone; Atrial Fibrillation; Cardiac Catheterization; Electric Countershock; Humans; Injection S

2019